Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.

Porcelli L, Iacobazzi RM, Di Fonte R, Serratì S, Intini A, Solimando AG, Brunetti O, Calabrese A, Leonetti F, Azzariti A, Silvestris N.

Cancers (Basel). 2019 Mar 7;11(3). pii: E330. doi: 10.3390/cancers11030330.

2.

Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study.

Beleù A, Calabrese A, Rizzo G, Capelli P, Bellini N, Caloggero S, Calbi R, Tinazzi Martini P, De Robertis R, Carbognin G, Marchegiani G, Scarpa A, Salvia R, Bassi C, D'Onofrio M.

Cancers (Basel). 2019 Feb 25;11(2). pii: E267. doi: 10.3390/cancers11020267.

3.

Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis.

Arabi YM, Al-Hameed F, Burns KEA, Mehta S, Alsolamy SJ, Alshahrani MS, Mandourah Y, Almekhlafi GA, Almaani M, Al Bshabshe A, Finfer S, Arshad Z, Khalid I, Mehta Y, Gaur A, Hawa H, Buscher H, Lababidi H, Al Aithan A, Abdukahil SAI, Jose J, Afesh LY, Al-Dawood A; Saudi Critical Care Trials Group.

N Engl J Med. 2019 Apr 4;380(14):1305-1315. doi: 10.1056/NEJMoa1816150. Epub 2019 Feb 18.

PMID:
30779530
4.

Angiogenesis in adenosquamous cancer of pancreas.

Silvestris N, Danza K, Longo V, Brunetti O, Fucci L, Argentiero A, Calabrese A, Cataldo I, Tamma R, Ribatti D, Tommasi S.

Oncotarget. 2017 Sep 27;8(56):95773-95779. doi: 10.18632/oncotarget.21319. eCollection 2017 Nov 10.

5.

Survival of cancer patients in Italy.

Coviello V, Buzzoni C, Fusco M, Barchielli A, Cuccaro F, De Angelis R, Giacomin A, Luminari S, Randi G, Mangone L; AIRTUM Working Group.

Epidemiol Prev. 2017 Mar-Apr;41(2 Suppl 1):1-244. doi: 10.19191/EP17.2S1.P001.017. English, Italian.

6.

Multimodal treatment of resectable pancreatic ductal adenocarcinoma.

Silvestris N, Brunetti O, Vasile E, Cellini F, Cataldo I, Pusceddu V, Cattaneo M, Partelli S, Scartozzi M, Aprile G, Casadei Gardini A, Morganti AG, Valentini V, Scarpa A, Falconi M, Calabrese A, Lorusso V, Reni M, Cascinu S.

Crit Rev Oncol Hematol. 2017 Mar;111:152-165. doi: 10.1016/j.critrevonc.2017.01.015. Epub 2017 Feb 4. Review.

PMID:
28259290
7.

Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer.

Azzariti A, Porcelli L, Brunetti O, Del Re M, Longo V, Nardulli P, Signorile M, Xu JM, Calabrese A, Quatrale AE, Maiello E, Lorusso V, Silvestris N.

World J Gastroenterol. 2016 Jul 21;22(27):6287-95. doi: 10.3748/wjg.v22.i27.6287.

8.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

9.

Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.

Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L.

Radiol Med. 2016 Feb;121(2):132-43. doi: 10.1007/s11547-015-0581-6. Epub 2015 Sep 9.

PMID:
26349573
10.

Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.

AIRTUM Working Group.

Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 1):1-122. English, Italian. Erratum in: Epidemiol Prev. 2016 Jan-Feb;40(1):76.

11.

[Improving cultural competence: a European project].

Georges Y, Martin V, Saillant M, Merle M, Durier MC, Pérel B, Régnier J, Gauthier S, Calabrese A, Brialon T, Oumouch K; Collectif du projet IENE 2 France.

Krankenpfl Soins Infirm. 2013;106(1):64-7. French. No abstract available.

PMID:
23405454

Supplemental Content

Loading ...
Support Center